Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
3 trials
Recent
Start date
Enrollment
Phase 3
×
Lymphoma
×
obinutuzumab
×
Clear all
Filters
3
NCT06084936
2026-03-03
GLOBRYTE
Hoffmann-La Roche
Phase 3
Recruiting
182 enrolled
NCT06191744
2026-03-03
EPCOREâ„¢FL-2
Genmab
Phase 3
Recruiting
1,095 enrolled
NCT05929222
2025-12-24
FIL_GAZEBO
Fondazione Italiana Linfomi - ETS
Phase 3
Recruiting
190 enrolled